Huadong Medicine
Huadong Medicine is mainly engaged in the production and sales of antibiotics, proprietary Chinese medicines, chemical synthetic drugs
Business Model:
Revenue: $4.3B
Employees: 5,001-10,000
Rankings
Industries / Tags:
Detailed Huadong Medicine Information
Geographic Data
Address: No. 866 Mogan Mountain Road
City: Hangzhou
State: zhejiang province
Zip: 310011
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
6,849,799Website Global Rank
742Website Monthly Traffic
Twitter Followers
Description
Huadong Medicine is a manufacturer and distributor of esthetic products and chemical drugs to the pharmaceutical industry.
Contact Phone:
Contact Email:
Huadong Medicine went public on 1/28/2000 on the SZSE
Listed Exchange:
SZSE
IPO Date:
1/28/2000
Ticker Symbol:
000963
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2020 | R2 Technologies | Series B | 10M |
| 11/1993 | NINGBO DONGHAI BANK | Angel Round | 0 |
| 4/2022 | Ashvattha Therapeutics | Series B | 0 |
| 2/2022 | Heidelberg Pharma AG | Post-IPO Equity | 0 |
| 2/2021 | R2 Technologies | Series B | 10M |
| 8/2022 | Heidelberg Pharma | Post-IPO Secondary | 89.3M |
| 8/2022 | Heidelberg Pharma | Post-IPO Equity | 15.9M |
| 4/2022 | Ashvattha Therapeutics | Series B | 0 |
| 2/2022 | Heidelberg Pharma AG | Post-IPO Equity | 0 |
| 2/2021 | R2 Technologies | Series B | 0 |
| 4/2020 | R2 Technologies | Series B | 0 |
| 11/1993 | NINGBO DONGHAI BANK | Angel Round | 0 |
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
